Are Gene Polymorphisms Related to Treatment Outcomes of Methotrexate in Patients with Rheumatoid Arthritis? A Systematic Review and Meta-analysis
Authors:
- 19 December 2016
- journal article
- review article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 18 (2) , 175-195
Abstract
Aim: Identifying the predictors of responsiveness and adverse events in methotrexate (MTX) treated patients with rheumatoid arthritis (RA) has been the focus of most concern, but still without consistent consensus. Methods: PubMed and OVID EMBASE were searched to collect relevant studies that addressed correlations between gene polymorphisms and efficacy and/or toxicity in MTX-treated RA patients. Allelic, recessive, dominant and over-dominant model were applied. Results: A total of 68 studies were included. For associations with efficacy, AMPD1 34C>T polymorphism was related to responsiveness in dominant model (odds ratio [OR]: 1.77; 95% CI: 1.19–2.63) and over-dominant model (OR: 1.59; 95% CI: 1.04–2.45). ATIC T675C polymorphism had association with responsiveness in recessive model (OR: 2.54; 95% CI: 1.23–5.26). For associations with toxicity, polymorphisms in TYMS 1494 del6 and FPGS rs10106 were correlated to absenting overall adverse events in recessive model (OR: 0.68; 95% CI: 0.49–0.95) and dominan...Keywords
Funding Information
- China Scholarship Council (201606240021)
This publication has 79 references indexed in Scilit:
- Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate actionArthritis Research & Therapy, 2012
- The Frequency of A1298C and C677T Polymorphisms of the Methylentetrahydrofolate Gene in Turkish Patients with Rheumatoid Arthritis: Relationship with Methotrexate ToxicityThe Open Rheumatology Journal, 2011
- Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexatePharmacogenetics and Genomics, 2010
- Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexateRheumatology, 2009
- Metaanalysis of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms Affecting Methotrexate ToxicityThe Journal of Rheumatology, 2009
- Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTXRheumatology, 2008
- QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countriesAnnals of the Rheumatic Diseases, 2007
- A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent‐onset rheumatoid arthritisArthritis & Rheumatism, 2007
- Methotrexate pharmacogenomicsAnnals of the Rheumatic Diseases, 2006
- Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single‐nucleotide polymorphisms in genes coding for folate pathway enzymesArthritis & Rheumatism, 2006